Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity

Area of Science:

• Immunology
• Aging Research
• Molecular Biology

Background:

• Immune system function, particularly T cell responses to vaccination, declines with advancing age.
• Age-related immune dysfunction impacts vaccine efficacy in older adults.

Purpose of the Study:

• To investigate the molecular mechanisms underlying age-associated decline in T cell receptor (TCR)-induced signaling in CD4(+) T cells.
• To identify potential targets for restoring immune responses in the elderly.

Main Methods:

• Analysis of extracellular signal-regulated kinase (ERK) phosphorylation in naive CD4(+) T cells from young and elderly individuals.
• Assessment of dual-specificity phosphatase 6 (DUSP6) protein expression and its regulation by miR-181a.
• Intervention studies involving miR-181a reconstitution, siRNA-mediated DUSP6 repression, and DUSP6 inhibition.

Main Results:

• An age-associated defect in TCR-induced ERK phosphorylation was identified in naive CD4(+) T cells.
• Increased DUSP6 protein expression, due to reduced miR-181a repression, was responsible for the defective ERK signaling.
• Restoring miR-181a or inhibiting DUSP6 improved CD4(+) T cell activation, proliferation, and T helper type 1 differentiation.

Conclusions:

• DUSP6 is a key mediator of age-associated T cell dysfunction.
• Targeting DUSP6 represents a promising strategy to rejuvenate T cell responses in the elderly.
• Enhancing T cell function in the elderly could improve vaccine efficacy.